Publications Database

Akhondzadeh S. et al. (2008)

A double-blind placebo controlled trial of piracetam added to risperidone in patients with autistic disorder.

Child Psychiatry and Human Development

39(3), pp. 237-245

Read Abstract (New Window)

Awad G. A. (1996)

The use of selective serotonin reuptake inhibitors in young children with pervasive developmental disorders: some clinical observations.

Canadian Journal of Psychiatry

August, 41(6), pp. 361-366

Read Abstract (New Window)

Becker M. M. et al.

Improvement in symptoms of autism spectrum disorder in children with the use of gastrin-releasing peptide: An open trial.

Clinical Neuropharmacology

Read Abstract (New Window)

Boyd K. , Woodbury-Smith M. R. , Szatmari P. (2011)

Managing anxiety and depressive symptoms in adults with autism-spectrum disorders.

Journal of Psychiatry and Neuroscience

36(4), E 35-36

Read Full (New Window)

Couturier J. . L. , Nicolson R. (1992)

A retrospective assessment of citalopram in children and adolescents with pervasive developmental disorders.

Journal of Child and Adolescent Psychopharmacology

12(3), pp. 243-248

Read Abstract (New Window)

D'Urso G. et al. (2014)

Transcranial direct current stimulation for autistic disorder.

Biological Psychiatry

September, 1(76), e5-6.

Read Abstract (New Window)

Davazno P. , King B. H. (1996)

Open trial lamotrigine in the treatment of self-injurious behavior in an adolescent with profound mental retardation.

Journal of Child and Adolescent Psychopharmacology

6(4), pp. 273-279

Read Abstract (New Window)

Dhossche D. M. , Reti I. M. , Wachtel L. E. (2009)

Catatonia and autism: A historical review, with implications for electroconvulsive therapy.

Journal of ECT

25(1), pp. 19-22

Read Abstract (New Window)

ElChaar G. M. et al. (2004)

Efficacy and safety of naltrexone use in pediatric patients with autistic disorder.

Mental Retardation and Developmental Disabilities Research Reviews

10(3), pp. 193-200.

Read Abstract (New Window)

Ghanizadeh A. , Sahraeizadeh A. , Berk M. (2014)

A head-to-head comparison of aripiprazole and risperidone for safety and treating autistic disorders, a randomized double blind clinical trial.

Child Psychiatry and Human Development

45(2), pp. 185-192.

Read Abstract (New Window)

Hamrin V. et al. (2008)

Psychopharmacological treatment of non-comorbid and comorbid pervasive developmental disorder and pediatric bipolar disorder.

Minerva Pediatrics

60(1), pp. 87-101

Read Abstract (New Window)

Hellings J. A. et al. (1996)

Sertraline response in adults with mental retardation and autistic disorder

Journal of Clinical Psychiatry

57(8), pp. 333-336

Read Abstract (New Window)

Hilty D. M. , Rodriguez G. D. , Hales R. E. (1998)

Intravenous valproate for rapid stabilization of agitation in neuropsychiatric disorders.

Journal of Neuropsychiatry and Clinical Neurosciences

10(3), pp. 365-366

Read Full (New Window)

King B. H. et al. (2001)

Double-blind, placebo-controlled study of amantadine hydrochloride in the treatment of children with autistic disorder.

Journal of the American Academy of Child and Adolescent Psychiatry

40(6), pp. 658-665

Read Abstract (New Window)

Kolmen B. K. et al. (1995)

Naltrexone in young autistic children: a double-blind, placebo-controlled crossover study.

Journal of the American Academy of Child and Adolescent Psychiatry

34(2), pp. 223-231

Read Abstract (New Window)

LeLord G. , Callaway E. , Muh J. (1982)

Clinical and biological effects of high doses of vitamin B6 and magnesium on autistic children.

Acta Vitaminologica et Enzymologica

4(1), pp. 27-44

Read Abstract (New Window)

Martin A. et al. (1992)

Open-label quetiapine in the treatment of children and adolescents with autistic disorder.

Journal of Child and Adolescent Psychopharmacology

9(2), pp. 99-107

Read Abstract (New Window)

Martineau J. , Barthélémy C. , LeLord G. (1986)

Long-term effects of combined vitamin B6-magnesium administration in an autistic child.

Biological Psychiatry

21(5), pp. 511-518

Martineau J. et al. (1985)

Vitamin B6, magnesium, and combined B6-Mg: therapeutic effects in childhood autism.

Biological Psychiatry

20(5), pp. 467-478

Read Abstract (New Window)

Masi G. et al. (2009)

Aripiprazole monotherapy in children and young adolescents with pervasive developmental disorders: a retrospective study.

CNS Drugs

23(6), pp. 511-521

Read Abstract (New Window)